ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE earnings call, live and summarised
ALFA Concalls Every earnings call, live and summarised

Earnings calls

Viyash Scientific concalls

Every Viyash Scientific earnings call we streamed: the live audio and our summary of what management said.

Calls

Sat, 14 Nov

Viyash Scientific

VIYASHQ2 FY27 earnings call

Q2 revenue ₹988 Cr (+16.2%) and PAT ₹85 Cr (+16.1%) are real but base-aided. Q2 EBITDA margin fell to 21.1% from 22.1%, and management leans on 2028-30 launches.

Summary ready

Q2 FY27: key takeaways

Call page →

Q2 revenue ₹988 Cr (+16.2%) and PAT ₹85 Cr (+16.1%) are real but base-aided. Q2 EBITDA margin fell to 21.1% from 22.1%, and management leans on 2028-30 launches.

Outlook

Guides PAT growth above 50% in FY27 (H1 +49%). Capex ~₹150 Cr over two years. ₹20 Cr loan prepayment considered; Europe launch next year.

Earlier call summaries

All →
10:35 IST BSE
Earnings Call

Viyash Scientific Earnings Call: Key Takeaways

Viyash reports a transformative Q4 FY26 with EBITDA surpassing ₹200cr. Revenue rose 19.1% YoY to ₹920cr, driven by integration synergies and a shift toward high-potent human and animal health products.

Viyash Scientific Ltd: key numbers

Share price
₹233.36
Market cap
₹10,314 Cr
Revenue (annual)
₹3,420 Cr
Net profit (annual)
₹177.3 Cr
P/E (TTM)
44.4×Sector 49.0×
Promoter holding
49.24%-12.07% QoQ
FII holding
2.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.